CVS Health Corporation $CVS Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. lowered its position in shares of CVS Health Corporation (NYSE:CVS) by 1.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 66,104 shares of the pharmacy operator’s stock after selling 646 shares during the quarter. Securian Asset Management Inc.’s holdings in CVS Health were worth $4,560,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of CVS. Avidian Wealth Enterprises LLC raised its stake in CVS Health by 100.2% during the second quarter. Avidian Wealth Enterprises LLC now owns 6,071 shares of the pharmacy operator’s stock worth $419,000 after purchasing an additional 3,038 shares during the period. Lyell Wealth Management LP purchased a new position in CVS Health during the second quarter worth approximately $212,000. Unison Advisors LLC raised its stake in CVS Health by 1.0% during the second quarter. Unison Advisors LLC now owns 54,864 shares of the pharmacy operator’s stock worth $3,785,000 after purchasing an additional 564 shares during the period. Stephens Inc. AR raised its stake in CVS Health by 12.0% during the second quarter. Stephens Inc. AR now owns 30,620 shares of the pharmacy operator’s stock worth $2,112,000 after purchasing an additional 3,285 shares during the period. Finally, Beverly Hills Private Wealth LLC raised its stake in CVS Health by 30.6% during the second quarter. Beverly Hills Private Wealth LLC now owns 6,065 shares of the pharmacy operator’s stock worth $418,000 after purchasing an additional 1,421 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of recent analyst reports. Leerink Partners increased their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Jefferies Financial Group raised their target price on shares of CVS Health from $80.00 to $92.00 in a research note on Wednesday, October 15th. Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Sunday, September 21st. Finally, Mizuho raised their target price on shares of CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.57.

CVS Health Stock Performance

CVS Health stock opened at $83.06 on Wednesday. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $83.52. The company has a market capitalization of $105.34 billion, a price-to-earnings ratio of 23.20, a price-to-earnings-growth ratio of 0.91 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The firm’s fifty day moving average price is $74.70 and its 200 day moving average price is $68.36.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. During the same quarter in the previous year, the firm posted $1.83 EPS. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.2%. CVS Health’s payout ratio is 74.30%.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is owned by company insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.